Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05645393 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Estradiol Topical Products
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
NCT05645393: Completed Early Phase 1 study, sponsored by University of Maryland, Baltimore.
NCT05645393 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 4 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05645393, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The aim of the present study is to determine if two products can deliver bioequivalent amounts of estrogen (estradiol, estriol, and estrone).
Primary Outcome
serum concentrations
Interventions
- DRUG topical estrogen product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2025-03-30 |
| Phase | Early Phase 1 |
What the finished NCT05645393 record still lists
NCT05645393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which topical estrogen product is the first listed.
NCT05645393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05645393 about?
NCT05645393 is a clinical study titled "Effect of Estradiol Topical Products". The aim of the present study is to determine if two products can deliver bioequivalent amounts of estrogen (estradiol, estriol, and estrone).
What is the current status of trial NCT05645393?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2024-06-05. Estimated completion is 2025-03-30.
What interventions are being tested in trial NCT05645393?
The interventions under investigation include: topical estrogen product (DRUG).
Who is sponsoring clinical trial NCT05645393?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05645393's enrollment target sits among peer trials
4 1922nd of 2000 higher than 53 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI